Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
|2||Active, not recruiting||
VX15/2503 Treatment for Huntington's Disease
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
† Study has passed its completion date and status has not been verified in more than two years.